| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,013 |
11,081 |
$612K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,240 |
4,849 |
$392K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,478 |
1,434 |
$113K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,379 |
2,321 |
$108K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,880 |
5,714 |
$99K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,076 |
1,041 |
$83K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
775 |
752 |
$56K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,354 |
1,308 |
$48K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
838 |
804 |
$21K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
217 |
214 |
$18K |
| 96160 |
|
5,163 |
4,993 |
$15K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
155 |
155 |
$13K |
| 96161 |
|
4,263 |
4,125 |
$11K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
425 |
389 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
133 |
116 |
$6K |
| 90474 |
|
151 |
146 |
$3K |
| 92551 |
|
480 |
429 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
137 |
96 |
$2K |
| 99173 |
|
463 |
427 |
$450.16 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$379.02 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$178.77 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
14 |
$140.33 |
| 90686 |
|
1,279 |
1,101 |
$51.47 |
| 90700 |
|
579 |
542 |
$1.09 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
13 |
$0.48 |
| 90713 |
|
254 |
235 |
$0.01 |
| 90648 |
|
253 |
231 |
$0.01 |
| 90670 |
|
196 |
178 |
$0.01 |
| 90680 |
|
76 |
67 |
$0.00 |
| 90716 |
|
32 |
29 |
$0.00 |
| 90656 |
|
29 |
29 |
$0.00 |
| 99000 |
|
119 |
117 |
$0.00 |
| 90688 |
|
108 |
99 |
$0.00 |
| 99072 |
|
559 |
403 |
$0.00 |
| 99001 |
|
55 |
48 |
$0.00 |
| 90633 |
|
57 |
50 |
$0.00 |
| 90707 |
|
31 |
30 |
$0.00 |